Jiangsu Kanion Pharmaceutical Co (SHSE:600557) E10: ¥0.69 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600557 Jiangsu Kanion Pharmaceutical Co Ltd SHSE:600557
82 GF Score
Price ¥12.94
GF Value ¥13.70
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Jiangsu Kanion Pharmaceutical Co E10?

Jiangsu Kanion Pharmaceutical Co SHSE:600557 -5.06% 82 E10 is ¥0.69 as of Mar. 2026. GuruFocus rates SHSE:600557 with a GF Score™ of 82/100 and a GF Value™ of ¥13.70 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jiangsu Kanion Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.140. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Jiangsu Kanion Pharmaceutical Co's average E10 Growth Rate was -1.40% per year. During the past 3 years, the average E10 Growth Rate was 1.00% per year. During the past 5 years, the average E10 Growth Rate was 2.80% per year. During the past 10 years, the average E10 Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Jiangsu Kanion Pharmaceutical Co was 20.20% per year. The lowest was 1.00% per year. And the median was 9.60% per year.

As of today (2026-07-17), Jiangsu Kanion Pharmaceutical Co's current stock price is ¥12.94. Jiangsu Kanion Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥0.69. Jiangsu Kanion Pharmaceutical Co's Shiller PE Ratio of today is 18.75.

During the past 13 years, the highest Shiller PE Ratio of Jiangsu Kanion Pharmaceutical Co was 46.42. The lowest was 14.49. And the median was 23.36.


Jiangsu Kanion Pharmaceutical Co  (SHSE:600557) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jiangsu Kanion Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=12.94/0.69
=18.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Jiangsu Kanion Pharmaceutical Co was 46.42. The lowest was 14.49. And the median was 23.36.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Jiangsu Kanion Pharmaceutical Co E10 Related Terms


Jiangsu Kanion Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Jiangsu Kanion Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Kanion Pharmaceutical Co E10 Chart

Jiangsu Kanion Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.67 0.69 0.70 0.69

Jiangsu Kanion Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.69 0.68 0.69 0.69

SHSE:600557 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Kanion Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Kanion Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Kanion Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Kanion Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:600557
82GF Score
Jiangsu Kanion Pharmaceutical Co Ltd SHSE:600557
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Kanion Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jiangsu Kanion Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.14/116.3033*116.3033
=0.140

Current CPI (Mar. 2026) = 116.3033.

Jiangsu Kanion Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.180 101.400 0.206
201609 0.170 102.400 0.193
201612 0.130 102.600 0.147
201703 0.140 103.200 0.158
201706 0.170 103.100 0.192
201709 0.180 104.100 0.201
201712 0.140 104.500 0.156
201803 0.160 105.300 0.177
201806 0.180 104.900 0.200
201809 0.180 106.600 0.196
201812 0.180 106.500 0.197
201903 0.180 107.700 0.194
201906 0.230 107.700 0.248
201909 0.220 109.800 0.233
201912 0.230 111.200 0.241
202003 0.140 112.300 0.145
202006 0.110 110.400 0.116
202009 0.080 111.700 0.083
202012 0.110 111.500 0.115
202103 0.150 112.662 0.155
202106 0.130 111.769 0.135
202109 0.080 112.215 0.083
202112 0.200 113.108 0.206
202203 0.190 114.335 0.193
202206 0.180 114.558 0.183
202209 0.120 115.339 0.121
202212 0.260 115.116 0.263
202303 0.240 115.116 0.242
202306 0.220 114.558 0.223
202309 0.130 115.339 0.131
202312 0.200 114.781 0.203
202403 0.230 115.227 0.232
202406 0.180 114.781 0.182
202409 0.130 115.785 0.131
202412 0.140 114.893 0.142
202503 0.150 115.116 0.152
202506 0.100 114.907 0.101
202509 0.100 115.471 0.101
202512 0.190 115.832 0.191
202603 0.140 116.303 0.140

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.69 mean?
Jiangsu Kanion Pharmaceutical Co (SHSE:600557) has a E10 of ¥0.69 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jiangsu Kanion Pharmaceutical Co and its competitors.
Is Jiangsu Kanion Pharmaceutical Co's E10 too high?
Jiangsu Kanion Pharmaceutical Co's current E10 is ¥0.69. Overall, Jiangsu Kanion Pharmaceutical Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Kanion Pharmaceutical Co's E10 compare to ZTS and UTHR?
Jiangsu Kanion Pharmaceutical Co's E10 of ¥0.69 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jiangsu Kanion Pharmaceutical Co and its competitors. Jiangsu Kanion Pharmaceutical Co's current E10 is ¥0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Kanion Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Kanion Pharmaceutical Co (SHSE:600557) is currently considered Fairly Valued. The stock's GF Value™ is ¥13.70, compared to a current price of ¥12.94 — trading 5.5% below its estimated fair value. The current E10 is ¥0.69. Jiangsu Kanion Pharmaceutical Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Jiangsu Kanion Pharmaceutical Co (SHSE:600557), the current E10 is ¥0.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Kanion Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥12.94 is trading 5.5% below its estimated GF Value™ of ¥13.70. GuruFocus considers Jiangsu Kanion Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600557:

  • E10: ¥0.69
  • GF Value™: ¥13.70 vs. price of ¥12.94 (5.5% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600557 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jiangsu Kanion Pharmaceutical Co Business Description

Address No. 58 Haichang South Road, Xinpu District, Jiangsu, Lianyungang, CHN, 222001
Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.
82GF Score

Get the complete analysis for SHSE:600557

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.94
Price
¥13.70
GF Value